HERMES PHARMA
  • SearchMobile only
  • ContactMobile only
  • Why HERMES PHARMA
    • Full-service provider
      • Project management
      • Research & development
      • Formulation development
      • Analytical services
      • Clinical studies
      • Regulatory services
      • Sourcing
      • Manufacturing
      • Quality management
      • Logistics & order management
    • Quality-first approach
      • Our QbD/PAT-driven processes
      • Specialist manufacturing facilities
    • Sustainability & ESG
      • Our commitment to sustainability
    • History
    • Executive team
  • Dosage forms & drug delivery
    • Swallowing difficulties
    • User-friendly dosage forms
      • Orally disintegrating granules
      • Chewable tablets
      • Effervescent tablets
      • Instant drinks
      • Lozenges
    • Your route to new products
  • Innovation
    center
    • Featured products
      • Magnesium
      • Macrogol
    • Pioneering technologies
      • Flavoring
      • Taste masking technologies
      • Granulation technologies
      • Serialization
    • User-friendly packaging
      • Innovative packaging options
  • News & media center
    • News & media center
    • Memberships
  • Jobs & careers

Contact

EN DE

Your Search

Reset
  • All results
  • Pages
  • Articles in the press
  • Brochures
  • Company news
  • Educational resources
  • News
  • Podcasts
  • Press releases
  • Videos
  • Events
18 Results
  • Press releases

    HERMES PHARMA announces €25 million investment to bolster capacity

    The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturingHERMES PHARMA manufacturing site in Wolfratshausen, GermanyHERMES PHARMA manufacturing site in Wolfsberg, AustriaPullach, Germany, 26 September 2023 – HERMES PHARMA, the leading expert in user-friendly oral dosage forms, has announced …

  • Press releases

    HERMES PHARMA Announces Spin-out from HERMES Arzneimittel

    Dr Thomas Hein, Senior Vice President Commercial & Regulatory Affairs, HERMES PHARMADr Andreas Schrepfer, Managing Director, HERMES PHARMAPullach, Germany, 01 July 2021 – HERMES PHARMA, previously a division of HERMES Arzneimittel GmbH, today announces that it has formed a separate legal entity named HERMES PHARMA GmbH. …

  • Press releases

    HERMES PHARMA Achieves Top Rating for Sustainability Performance from EcoVadis

    Recognition for the company’s commitment and continuous efforts to meet international CSR standardsPULLACH, Germany, November 12, 2019 — HERMES PHARMA, the leading expert in user-friendly oral dosage forms,today announced that the company together with its affiliates was awarded the Silver Medal by the international rating agency, EcoVadis. This …

  • Press releases

    HERMES PHARMA Opens New Era of Delivering Food Supplements at Vitafoods Europe 2019

    The expert in user-friendly dosage forms launches HERMES NutriCaps, a novel and innovative way to deliver food supplementsHERMES NutriCaps are a finalist for the NutraIngredients Awards 2019 in the category “Editors Award for Functional Food Innovation.”HERMES PHARMA will be exhibiting at Vitafoods 2019 in Geneva. …

  • Press releases

    Johannes Burges Family Foundation

    Family Foundation Ensures Future Independence of HERMES PHARMA and Other Companies of the Johannes Burges GroupPullach, Germany, February 12, 2019 — In a forward-looking move, the Johannes Burges Group (JBU) has set the course for the future of its operations, heralding a new chapter in its …

  • Press releases

    HERMES PHARMA Obtains Prestigious GMP Certification from Russian Authorities

    The successful inspection allows HERMES PHARMA to manufacture for the Russian marketPullach, Germany, January 16, 2018 — HERMES PHARMA, the expert in user-friendly oral dosage forms, successfully completed the Good Manufacturing Practices (GMP) inspection of its production facilities by Russian authorities. The German plant in Wolfratshausen, …

  • Press releases

    HERMES PHARMA Improves Opening of Tablet Tubes Used for Lozenges, Effervescent and Chewable Tablets

    New Patented Desiccant Stopper Makes Products Even More User-FriendlyPullach, Germany, Oct 18, 2016 – HERMES PHARMA, the expert in user-friendly oral dosage forms, has announced the availability of a new desiccant stopper. The patent-protected stopper features a two-step, easy-opening technique suitable for multi-dose tablet tube containers.Often, …

  • Press releases

    HERMES PHARMA Awarded European Organic Certificate

    Wolfratshausen GMP Facility Meets Organic Food Trend RequirementsPullach, Germany, May 10, 2016 – HERMES PHARMA, the expert in user-friendly oral dosage forms, has announced that its facility in Wolfratshausen, Germany now also meets the requirements to produce and package organic food substances. The company has been …

  • Press releases

    HERMES PHARMA Makes Hot Melt Coating Available for the Pharma Industry

    Commercial Production in GMP Environment Started to Mask the Sour and Metallic Taste of AcetylcysteinePullach, Germany, January 26, 2016 – HERMES PHARMA, the expert in user-friendly solid oral dosage forms, has announced the commercial implementation of hot melt coating (HMC) in its production facility. The implementation …

  • Press releases

    User-Friendly Dosage Form Expert, HERMES PHARMA, Brings Easy-to-Swallow Medicines to US Market

    HERMES PHARMA has today announced plans to ramp up its expansion into the US marketPullach, Germany, August 13, 2015 – HERMES PHARMA, Europe’s largest developer and manufacturer of user-friendly solid oral dosage forms, has today announced plans to ramp up its expansion into the US market. …

1 2
Next Page
HERMES PHARMA

Privacy policy

Cookie settings

Whistleblowing system

Imprint

Terms of use

Terms & conditions

Sitemap

LinkedIn

Youtube

Code of conduct

Contact
Search
LinkedIn